福蓉科技(603327.SH):上半年淨利潤1.04億元,同比下降34.95%
格隆匯8月21日丨福蓉科技(603327.SH)公佈2024年半年度報吿,報吿期實現營業收入10.43億元,同比增長20.29%;歸屬於上市公司股東的淨利潤1.04億元,同比下降34.95%;歸屬於上市公司股東的扣除非經常性損益的淨利潤7129.33萬元,同比下降46.77%;基本每股收益0.1401元。
公司在高精度鋁製結構件材料行業深耕細作多年,不斷進行技術創新,形成了深厚的技術沉澱和具有自身特色的競爭優勢,使得公司在鋁製結構件材料行業一直保持領先地位。總體來説,公司的核心競爭力主要體現在技術、生產規模及快速響應、客户資源、產品質量、定製化服務等方面。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.